Evaluation of Teaching Pharmacoeconomics to Japanese Students

REFERENCES

• Drummond M, Rotten F, Brenna A et al. Economic evaluation of pharma-ceuticals: a European perspective. PharmacoEcon. 1993; 4:173–86.
   PubMedGoogle Scholar
• Jolicoeur LM, Jones-Grizzle Al, Boyer JO. Guidelines for performing a pharmacoeconomic analysis. Am .1 Hasp Pharm. 1992; 49:1741–7.
   PubMedGoogle Scholar
• Ohmichi H. Current pharmacoeconomic issues in Japanese healthcare. PharmacoEcon. 1994; 6:193–5.
   Google Scholar
• Johnson JA, Bootman JL. Pharmacoeconomic analysis in formulary deci-sions: an international perspective. Am J Hasp Pharm. 1994; 51:2593–8.
   PubMedGoogle Scholar
• Clouse JC. Pharmacoeconomics: a managed care perspective. Top Hasp Pharm Manage. 1994; 13:54–9.
   Google Scholar
• Jones-Grizzle At, Boatman JL. Pharmacoeconomics of genetically engine-ered drugs. PharmacoEcon 1992; 145–53.
   Google Scholar
• Skaer TL. Applying pharmacoeconomic and quality-of-life measures to the formulary management process. Hasp Formal. 1993; 28:577–84.
   Google Scholar
• St. Jean AD, Landis NT. The pharmacoeconomist-an emerging specialist in health care institutions. Am .1 Hosp Pharm. 1993; 50: 1062, 1066, 1068,1073.
   Google Scholar
• McCombs JS, Nichol MB. Pharmacy-enforced outpatient drug treatment protocols: a ease study of Medi-Cal restrictions for cefaclor. Ann Pharmacother. 1993; 27:155–61.
   Google Scholar
• Schrogie .1.1, Nash DB. Relationship between practice guidelines, formu-lary management, and pharmacoeconomic studies. Top Hosp Pharm Manage. 1994; 13: 38–46.
   Google Scholar
• Cimino MA, Rotstein CM, Moser JE. Assessment of cost-effective anti-biotic therapy in the management of infections in cancer patients. Ann Pharma-rather. 1994; 28:105–11,
   Google Scholar
• Gibaldi M, Sullivan SD. A look at cost-effectiveness. Pharmacotherapy. 1994; 14:399–414.
   Google Scholar
• Dao TD. Cost-benefit and cost-effectiveness analysis of drug therapy. Am J Hoop Pharm. 1985; 42:791–802.
   Google Scholar
• Eisenberg 1M. Clinical economics: a guide to the economic analysis of clinical practices. JAMA 1989; 262: 2879–86.
   Google Scholar
• Szcinbach SL, Juergens JP, Smith MC, Freeman RA. Content analysis of pharmacoeconomic appeals in pharmaceutical drug product advertisements. .1 Res Pharm Econ. 1991; 3:3.
   Google Scholar
• Draugalis JR, Jones-Grizzle AJ. Pharmacy education and pharmacoeco-nomics..1 Pharm Teach. 1991; 2:3–10.
   Google Scholar
• Juergens JP, Szeinbach SL, Smith MC. Will future pharmacists understand pharmacoeconomic research? Am J Pharm Educ. 1992; 56:135–40.
   Google Scholar
• Hokanson JA, Berina LF, Guernsey 13G, Allen JA, Goatee WH, Bryant SG. Do pharmacy schools need to increase the statistical education of their students? Am J Pharrn Educ. 1985; 49:46–9.
   Google Scholar
• Tsubaki T, Iga T, Chandler MHH. Health care and institutional pharmacy practice in Japan. Am J Hoop Pharm. 1994; 51:535–8.
   Google Scholar
• Olson C. Observations of a traveling pharmacist, part 3. Am J Hasp Pharrn. 1986; 43:730–5.
   Google Scholar
• Tatsuno M, Muraoka K, Nagai T. Japan. In: Spivey RN, Wertheimer At, Rucker TD, eds. International Pharmaceutical Services, New York: Pharmaceuti-cal Products Press; 1992; 303–34.
   Google Scholar
• Armstrong EP, Akaho E, Fuji i M. Japanese pharmacy: innovation mixed with tradition. Ann Pharmacother. 1995; 29:181–5.
   Google Scholar
• Nagai T, Tatsuno M. Pharmacy in Japan. Int Pharm J. 1990; 4:81–3.
   Google Scholar
• Japanese Society of Hospital Pharmacists: 1992 Report. Tokyo: The Japa-nese Society of Hospital Pharmacists; 1992; 1–38.
   Google Scholar
• Gourley DR, Fukuchi H, Barnett CW et al. Japanese hospital pharmacists concepts of pharmacy in the year 2010. Jpn J Hasp Pharm. 1994; 20:153–78.
   Google Scholar
• Review Committee for National Board Examination for Registered Phar-macists. Japan; 1994 Jun 2:6-28 (in Japanese).
   Google Scholar
• Fujii M. The present situation of education in pharmacy administration in Japan. Am J Pharrn Educ. 1993; 57:67–9.
   Google Scholar